Home›Companies›KayoThera

KayoThera, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 13, 2023·Suggest an edit

About KayoThera

KayoThera is a private company based in Seattle, Washington, incorporated in 2019 in Delaware. It has reported $11,206,366 raised in two offerings on Form D since June 2019. Its chief executive is Thong Le.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 11, 2022Mar 24, 2022amended Jul 13, 2023$10,456,366of $10.8M target14$746KEquityRule 506(b)Form D/A ↗2 earlier filings
May 29, 2019Jun 5, 2019$750,000fully sold1$750KEquityRule 506(b)Form D ↗
Total, two offerings$11,206,366

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on KayoThera's Form D filed Jul 13, 2023.

TL
Thong Le
Chief Executive Officer and director
Also a chief executive officer and director at Automera and CEO and director at Proniras.
ME
Mark Esposito
Executive officer and director
KM
Kendall Mohler
Executive officer and director
Also an executive officer at Automera.
IH
Ian Howes
Executive officer
Also an executive officer and promoter at Automera.

Earlier filings also listed Yibin Kang (director, last listed Jun 2019), James Golubieski (director, last listed Jun 2019) and George Heinrich (director, last listed Jun 2019).

Sources

  1. SECKayoThera, Inc. Form D/A, filed Mar 31, 2023
  2. SECKayoThera, Inc. Form D, filed Mar 24, 2022
  3. SECKayoThera, Inc. filing history